Aclaris Joins Nasdaq Biotech Index, Marking Milestone for Clinical-Stage Firm
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) said it has been added to the Nasdaq Biotechnology Index, a move that places the clinical-stage biopharmaceutical company among a select group …
Aclaris Joins Nasdaq Biotech Index, Marking Milestone for Clinical-Stage Firm Read More